Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial. - Zhao ZR; Liu SL; Zhou T; Chen G; Long H; Su XD; Zhang X; Fu JH; Lin P; Zhang LJ; Rong TH; Wu JD; et al. (The Lancet. Respiratory medicine, 2024)